IRMO, S.C. — A biotechnology company in Irmo has announced it will invest $4.1 million to expand operations and add 31 new jobs in Richland County.
Integrated Micro-Chromatography Systems Inc. (IMCS) creates, manufactures and distributes biotechnology products and services for an array of clients, including clinical and forensic toxicology labs, academic research facilities, federal government agencies and health science companies.
IMCS’ enzymes are used in drug testing labs, and drug discovery labs use the company’s micro separations products to discover antibodies that can be used to fight diseases such as COVID-19. IMCS is also using a federal grant to scale up production of new enzymes that will be used to make new therapeutic drugs for treating neurodegenerative diseases, such as Parkinson’s and Alzheimer’s.
The company, founded in 2013 by three Ph.D. scientists from the University of South Carolina in the university’s technology incubator, will maintain the Irmo site as a headquarters while combining work being done in existing facilities. IMCS has 40 full-time employees, with 600 clients in every U.S. state and 15 countries.